Thymosin Beta4: A Key Regulator of Actin Dynamics and Wound Healing
Philp D, Badamchian M, Scheremeta B, Nguyen M, Goldstein AL, Kleinman HK
Annals of the New York Academy of Sciences · Vol. 1019(1) · pp. 99–107 · 2004
Foundational study establishing Thymosin Beta-4 (TB-500) as a critical regulator of actin dynamics and wound healing. Demonstrates that TB-500 promotes cell migration, angiogenesis, and tissue remodeling through its actin-sequestering properties. The peptide's systemic distribution makes it uniquely effective for body-wide healing.
Citation
Key Findings
TB-500 promotes keratinocyte and endothelial cell migration essential for wound closure
Stimulates angiogenesis through upregulation of VEGF and other growth factors
Reduces inflammation while promoting tissue remodeling
Systemic distribution allows body-wide healing effects from a single injection site
Demonstrated efficacy in corneal, dermal, and cardiac wound healing models
Methodology
In vitro cell migration assays combined with in vivo wound healing models in mice. Includes mechanistic studies on actin dynamics and growth factor expression.
Limitations
Primarily in vitro and animal model data. Human clinical trials limited to cardiac applications.
Protocols Using This Research
Tags
Educational use only. Research summaries are provided for informational purposes. Always consult the original publication and a qualified healthcare provider before making clinical decisions.
Related Research
BPC-157: A Review of Its Healing Properties in Inflammatory Bowel Disease and Sy…
2016 · Strong Evidence
BPC-157 Accelerates Healing of Transected Rat Achilles Tendon and Promotes Angio…
2006 · Moderate Evidence
Thymosin Beta-4 Induces Adult Epicardial Progenitor Mobilization and Neovascular…
2007 · Strong Evidence
Build a protocol around this research
Our AI Advisor incorporates the latest research to build a personalized peptide protocol for your goals.
Start Assessment